SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001047469-99-016378
Filing Date
1999-04-26
Accepted
1999-04-26 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHED 13-G SC 13G 15294
  Complete submission text file 0001047469-99-016378.txt   17503
Mailing Address ONE KENDALL SQ BLDG 700 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ BUILD 700 CAMBRIDGE MA 02139 6172250600
CAMBRIDGE NEUROSCIENCE INC (Subject) CIK: 0000874384 (see all company filings)

IRS No.: 133319074 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-41681 | Film No.: 99601207
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice